✦ LIBER ✦

Safety and Efficacy After Conversion From Mycophenolate Mofetil to Enteric-Coated Mycophenolate Sodium: Results of a 1-Year Extension Study

✍ Scribed by K. Budde; G. Knoll; J. Curtis; L. Kahana; E. Pohanka; Y. Seifu; H.H. Neumayer

Book ID: 116930663
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 97 KB
Volume: 37
Category: Article
ISSN: 0041-1345
DOI: 10.1016/j.transproceed.2004.12.048

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and safety of conversion of myc

Efficacy and safety of conversion of mycophenolate mofetil to enteric-coated mycophenolate sodium in Mexican renal transplant children

✍ H. Reyes; A. M. Hernández; S. Valverde; A. Cataneo; A. Mendoza; I. Barrera; L. O 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 150 KB

Conversion to enteric-coated mycophenola

Conversion to enteric-coated mycophenolate sodium from mycophenolate mofetil in stable renal transplant patients: Results of an Asia-Pacific study

✍ Lee, Po-Huang; Vathsala, Anantharaman; Han, Duck Jong; Chan, Tak-Mao; Wong, Hin- 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 124 KB

Improvement of gastrointestinal symptoms

Improvement of gastrointestinal symptoms after conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in liver transplant patients

✍ Alexander H. Toledo; Laura Hendrix; Valorie Buchholz; Erin Fisher; Kimberly Newt 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 95 KB

Conversion from mycophenolate mofetil to

Conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in liver transplant patients presenting gastrointestinal disorders: A pilot study

✍ Jérôme Dumortier; Marie-Claude Gagnieu; Janine Salandre; Olivier Guillaud; Phili 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB

Gastrointestinal (GI) disorders are one of the main adverse events in patients treated by mycophenolic acid (MPA). The aim of this prospective study was to evaluate the effect of conversion from mycophenolate mofetil (MMF) to enteric-coated mycophenolate sodium (EC-MPS) in liver transplant patients

Complete Resolution of Severe Diarrhoea

Complete Resolution of Severe Diarrhoea after Conversion from Mycophenolate Mofetil to Enteric-coated Mycophenolate Sodium (myfortic®) in a Patient at High Immunological Risk

✍ Thomas Breidenbach, Marcus Spangenberg, Eckhard Nagel 📂 Article 📅 2006 🏛 Springer International Publishing AG 🌐 English ⚖ 117 KB

Improvement in Gastrointestinal and Heal

Improvement in Gastrointestinal and Health-related Quality of Life Outcomes After Conversion From Mycophenolate Mofetil to Enteric-coated Mycophenolate Sodium in Liver Transplant Recipients

✍ Sterneck, M.; Settmacher, U.; Ganten, T.; Sarrazin, C.; Speidel, N.; Broering, D 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 470 KB